Brain cholinergic terminal density utilizing [18F]‐fluoroethoxybenzovesamicol PET in adults with Down's syndrome: Relationship to amyloid PET and cognitive performance

Documents similaires

• Investigating the association between cholinergic integrity and amyloid burden using cholinergic anatomy and [18F]‐FEOBV PET in individuals with Down Syndrome from the ABC‐DS and TRC‐DS cohorts
  par: Jason K Russell, et autres
  Publié: (2024)
• Relationship between electrophysiological performance during an incidental memory task and cholinergic integrity in a pilot study in adults with Down syndrome
  par: Alexander C Conley, et autres
  Publié: (2024)
• Relationship of cholinergic basal forebrain atrophy with the time course of Alzheimer's disease pathology and cognitive decline in adults with Down syndrome: a longitudinal cohort study
  par: Jason K. Russell, et autres
  Publié: (2026)
• Assessing amyloid PET positivity and cognitive function in Down syndrome to guide clinical trials targeting amyloid
  par: Sophia Krasny, et autres
  Publié: (2024)
• Associations of plasma phospho‐Tau217 with amyloid‐PET and cognitive status in adults with Down syndrome
  par: Brecca Bettcher, et autres
  Publié: (2024)